Manifold, an AI-enabled medical analysis platform, introduced 5 new appointments to its management crew and two new members of its advisory crew.
Chris McMahon joins the corporate as chief folks officer, Alex Akersd as vice chairman of progress, Danielle Kowalski as vice chairman of authorized, Megan Ahigian as senior director of product and partnerships and Taylor Gleason as senior director of promoting.
McMahon, Ahigian and Gleason beforehand held comparable roles at Kyruus Well being, Akers served as VP of gross sales at Well being Catalyst and Kowalski was VP and deputy common counsel of HubSpot’s authorized and compliance operate.
Mike Longo and Chris Reisig will be a part of the corporate as go-to-market advisors. Longo beforehand labored as Veeva’s vice chairman of analysis and growth in North America.
“We’re thrilled to welcome among the business’s strongest leaders to assist us remodel medical research and knowledge operations with our AI-powered platform,” stated Vinay Seth Mohta, CEO and Co-Founding father of Manifold. “Our crew might be essential to rising our partnerships and increasing our options – reaching our imaginative and prescient of constructing it ten instances sooner and one-tenth the fee to hold out fashionable research and analytics.”
Healthcare knowledge firm ConcertAI introduced Dhiraj Carumbay has been appointed senior vice chairman and common supervisor of the corporate’s TeraRecon enterprise.
Carumbay managed enterprise items at RadNet, Amazon AWS, Philips Healthcare, Fujifilm, and GE HealthCare. At AWS, he oversaw Amazon’s cloud options for the healthcare and life sciences industries. Previous to that, he held enterprise management and international product roles at GE HealthCare.
“Dhiraj began his profession targeted on diagnostic imaging and instantly working healthcare supplier options utilizing AI – that was the important thing criterion we had for this management function,” Jeff Elton, CEO of ConcertAI, stated in a press release.
“His depth in imaging broadly, SaaS applied sciences, and AI, he’s uniquely suited to make sure our supplier and biopharma companions have probably the most superior applied sciences and knowledge to remodel the diagnostic and analysis expertise.”